Donepezil, also referred to in early publications as ‘E2020’, is a piperidine inhibitor of acetylcholinesterase (anti‐AChE) that has been widely prescribed for mild to moderate dementia in Alzheimer's disease (AD). This evidence concerns the gene ACHE and early-onset autosomal dominant Alzheimer disease.